1. Long Non-coding RNA Rhabdomyosarcoma 2-Associated Transcript Regulates Angiogenesis in Endothelial Cells
    Maha Alaqeeli et al, 2021, Frontiers in Physiology CrossRef
  2. MiRNA Influences in Neuroblast Modulation: An Introspective Analysis
    Vanessa Zammit et al, 2018, Genes CrossRef
  3. MicroRNA-141 enhances anoikis resistance in metastatic progression of ovarian cancer through targeting KLF12/Sp1/survivin axis
    Celia S. L. Mak et al, 2017, Molecular Cancer CrossRef
  4. LncRNA XIST accelerates cervical cancer progression via upregulating Fus through competitively binding with miR-200a
    Hong Zhu et al, 2018, Biomedicine & Pharmacotherapy CrossRef
  5. Non-Coding RNAs Participate in the Pathogenesis of Neuroblastoma
    Omidvar Rezaei et al, 2021, Frontiers in Oncology CrossRef
  6. Wild-Type and Mutant FUS Expression Reduce Proliferation and Neuronal Differentiation Properties of Neural Stem Progenitor Cells
    Eleonora Stronati et al, 2021, International Journal of Molecular Sciences CrossRef
  7. MicroRNA as a Potential Therapeutic Molecule in Cancer
    Joanna Szczepanek et al, 2022, Cells CrossRef
  8. GD2‐targeted immunotherapy and potential value of circulating microRNAs in neuroblastoma
    Sharareh Gholamin et al, 2018, Journal of Cellular Physiology CrossRef
  9. LncRNA SNHG15 contributes to proliferation, invasion and autophagy in osteosarcoma cells by sponging miR-141
    Ke Liu et al, 2017, Journal of Biomedical Science CrossRef
  10. Dichloroacetate affects proliferation but not apoptosis in canine mammary cell lines
    Tatjana P. Harting et al, 2017, PLOS ONE CrossRef
  11. The role of miR-200 family in the regulation of hallmarks of cancer
    Klaudia Klicka et al, 2022, Frontiers in Oncology CrossRef
  12. Novel Function of lncRNA ADAMTS9-AS2 in Promoting Temozolomide Resistance in Glioblastoma via Upregulating the FUS/MDM2 Ubiquitination Axis
    Yuanliang Yan et al, 2019, Frontiers in Cell and Developmental Biology CrossRef
  13. Current Challenges in the Management of Neuroblastoma
    Duncan Ayers, 2019, Neuroblastoma CrossRef
  14. The effect of dichloroacetate in canine prostate adenocarcinomas and transitional cell carcinomas in vitro
    Tatjana Harting et al, 2016, International Journal of Oncology CrossRef
  15. miR-4478 sensitizes ovarian cancer cells to irradiation by inhibiting Fus and attenuating autophagy
    Lingling Wang et al, 2021, Molecular Therapy - Nucleic Acids CrossRef
  16. Interaction of BACH2 with FUS promotes malignant progression of glioma cells via the TSLNC8–miR‐10b‐5p–WWC3 pathway
    Yang Yang et al, 2020, Molecular Oncology CrossRef
  17. Expression of IL-13Rα2 and FUS in glioma: clinicopathological and prognostic correlation
    Guang Cheng et al, 2023, BMC Neurology CrossRef
  18. High Expression MicroRNA-206 Inhibits the Growth of Tumor Cells in Human Malignant Fibrous Histiocytoma
    Dejian Li et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
  19. Identification of Specific Long Non-Coding Ribonucleic Acid Signatures and Regulatory Networks in Prostate Cancer in Fine-Needle Aspiration Biopsies
    Zehuan Li et al, 2020, Frontiers in Genetics CrossRef
  20. FUS/circ_002136/miR-138-5p/SOX13 feedback loop regulates angiogenesis in Glioma
    Zhenwei He et al, 2019, Journal of Experimental & Clinical Cancer Research CrossRef
  21. Noncoding RNA in drug resistant sarcoma
    Xiaoyang Li et al, 2017, Oncotarget CrossRef
  22. Long noncoding RNA XXYLT1-AS2 regulates proliferation and adhesion by targeting the RNA binding protein FUS in HUVEC
    Qi Wang et al, 2020, Atherosclerosis CrossRef
  23. LncRNA HCG18 is critical for vascular smooth muscle cell proliferation and phenotypic switching
    Yanjiao Lu et al, 2020, Human Cell CrossRef
  24. Role of non-coding RNAs in neuroblastoma
    Ali Arash Anoushirvani et al, 2023, Cancer Gene Therapy CrossRef
  25. MicroRNAs as prospective biomarkers, therapeutic targets and pharmaceuticals in neuroblastoma
    Natalia Andreeva et al, 2023, Molecular Biology Reports CrossRef